FI964537A0 - Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten - Google Patents
Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä vartenInfo
- Publication number
- FI964537A0 FI964537A0 FI964537A FI964537A FI964537A0 FI 964537 A0 FI964537 A0 FI 964537A0 FI 964537 A FI964537 A FI 964537A FI 964537 A FI964537 A FI 964537A FI 964537 A0 FI964537 A0 FI 964537A0
- Authority
- FI
- Finland
- Prior art keywords
- peroxynitrite
- pharmaceutical compositions
- methods
- same
- decomposition catalysts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24249894A | 1994-05-13 | 1994-05-13 | |
PCT/US1995/005886 WO1995031197A1 (en) | 1994-05-13 | 1995-05-09 | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
FI964537A0 true FI964537A0 (fi) | 1996-11-12 |
FI964537A FI964537A (fi) | 1997-01-10 |
Family
ID=22915009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI964537A FI964537A (fi) | 1994-05-13 | 1996-11-12 | Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0758892A1 (fi) |
JP (1) | JPH10500671A (fi) |
CN (1) | CN1222286C (fi) |
AU (1) | AU709553B2 (fi) |
BR (1) | BR9507643A (fi) |
CA (1) | CA2189528A1 (fi) |
CZ (1) | CZ323496A3 (fi) |
FI (1) | FI964537A (fi) |
HU (1) | HUT76327A (fi) |
NO (1) | NO964793L (fi) |
NZ (1) | NZ285648A (fi) |
PL (1) | PL317192A1 (fi) |
WO (1) | WO1995031197A1 (fi) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
WO1996009053A1 (en) * | 1994-09-20 | 1996-03-28 | Duke University | Oxidoreductase activity of manganic porphyrins |
JP2001521939A (ja) | 1997-11-03 | 2001-11-13 | デューク・ユニバーシティー | 置換されたポルフィリン類 |
EP1071474B1 (en) | 1998-04-24 | 2005-11-30 | Duke University | Substituted porphyrins |
US6632808B1 (en) | 1998-08-11 | 2003-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibitors of amyloid formation |
IL126953A0 (en) * | 1998-11-08 | 1999-09-22 | Yeda Res & Dev | Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives |
EP1013272A1 (en) * | 1998-12-23 | 2000-06-28 | Biomedical Primate Research Centre (BPRC) | Manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals |
DK1616869T3 (da) | 1999-01-25 | 2012-05-07 | Nat Jewish Health | Substituerede porphyriner og deres terapeutiske anvendelse |
US6448239B1 (en) | 1999-06-03 | 2002-09-10 | Trustees Of Princeton University | Peroxynitrite decomposition catalysts and methods of use thereof |
FR2806911B1 (fr) * | 2000-03-28 | 2003-01-10 | Univ Rene Descartes | Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires |
US20030050297A1 (en) * | 2001-01-19 | 2003-03-13 | Crapo James D. | Cancer therapy |
EP1439842A4 (en) | 2001-06-01 | 2009-09-02 | Nat Jewish Med & Res Center | OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE |
EP1513537A4 (en) | 2002-06-07 | 2006-09-06 | Univ Duke | SUBSTITUTED PORPHYRINS |
DE10240343A1 (de) * | 2002-08-27 | 2004-03-11 | Schering Ag | Peroxynitrit-Umlagerungskatalysatoren |
US6946466B2 (en) * | 2003-04-10 | 2005-09-20 | Schering Ag | Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US7705040B2 (en) * | 2005-10-07 | 2010-04-27 | The University Of Hong Kong | Reagents for highly specific detection of peroxynitrite |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US8232267B2 (en) | 2006-10-06 | 2012-07-31 | The Trustees Of Princeton University | Porphyrin catalysts and methods of use thereof |
EP2192899B1 (en) | 2007-08-28 | 2014-10-01 | Technion Research and Development Foundation, Ltd. | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
DK2300003T3 (da) | 2008-05-23 | 2014-05-26 | Nat Jewish Health | Forbindelser til anvendelse i behandling af skade forbundet med eksponering for en alkylerende art |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
RU2557655C1 (ru) * | 2014-06-10 | 2015-07-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ФГБОУ ВПО "ИГХТУ") | Никелевый комплекс 5,10,15,20-тетракис[3',5'-ди(2"-метилбутилокси)фенил]-порфина, проявляющий свойство стационарной фазы для газовой хроматографии |
CN107573259A (zh) * | 2017-09-25 | 2018-01-12 | 沅江华龙催化科技有限公司 | 一种金属卟啉催化芳香烯烃合成芳香腈的方法 |
EP4059496A1 (en) * | 2021-03-18 | 2022-09-21 | Institut Pasteur | Mntbap and m(iii) n-substituted pyridylporphyrins (mnps) for use in reversing sepsis-induced microglial cells alteration(s), associated long-term cognitive impairment, and/or for treating sepsis or sepsis-associated encephalopathy (sae), and/or related short and/or long-term symptoms or complications thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1291710C (en) * | 1985-04-30 | 1991-11-05 | Jerry C. Bommer | Tetrapyrrole therapeutic agents |
WO1987004071A1 (en) * | 1986-01-02 | 1987-07-16 | The University Of Toledo | Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
US4866054A (en) * | 1986-05-13 | 1989-09-12 | Chai-Tech Corporation | Antioxidant metallo-organic treatment of inflammation |
KR890701108A (ko) * | 1987-09-08 | 1989-12-19 | 원본미기재 | 종양요법의 독성효과를 반전시키기 위한 메탈로포르피린의 사용 |
DE69123704T2 (de) * | 1990-11-02 | 1997-04-30 | Zeneca Ltd | Polysubstituierte Phthalocyanine |
EP0557417A4 (en) * | 1990-11-14 | 1994-06-08 | Uab Research Foundation | Compositions for reducing oxidative injury |
FR2676738B1 (fr) * | 1991-05-22 | 1995-05-05 | Ir2M | Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante. |
GB9111689D0 (en) * | 1991-05-31 | 1991-07-24 | Johnson Matthey Plc | Gallium compounds |
KR0145953B1 (ko) * | 1991-07-19 | 1998-08-17 | 제임스 클리프튼 보올딩 | 슈퍼옥사이드의 불균화촉매로서 효과적인 질소를 포함하는 마크로사이클 릭리간드의 망간착물 |
WO1993010777A1 (en) * | 1991-11-25 | 1993-06-10 | Albion International, Inc. | Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals |
US5296466A (en) * | 1992-02-19 | 1994-03-22 | Board Of Regents, The University Of Texas System | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
US5403834A (en) * | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US6204259B1 (en) * | 1993-01-14 | 2001-03-20 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
GB9309387D0 (en) * | 1993-05-06 | 1993-06-16 | Wellcome Found | Nitric oxide scavengers |
GB9317686D0 (en) * | 1993-08-25 | 1993-10-13 | Johnson Matthey Plc | Pharmaceutical compositions |
-
1995
- 1995-05-09 PL PL95317192A patent/PL317192A1/xx unknown
- 1995-05-09 AU AU25120/95A patent/AU709553B2/en not_active Ceased
- 1995-05-09 JP JP7529755A patent/JPH10500671A/ja not_active Ceased
- 1995-05-09 WO PCT/US1995/005886 patent/WO1995031197A1/en not_active Application Discontinuation
- 1995-05-09 CZ CZ963234A patent/CZ323496A3/cs unknown
- 1995-05-09 EP EP95919143A patent/EP0758892A1/en not_active Withdrawn
- 1995-05-09 CA CA002189528A patent/CA2189528A1/en not_active Abandoned
- 1995-05-09 NZ NZ285648A patent/NZ285648A/xx unknown
- 1995-05-09 BR BR9507643A patent/BR9507643A/pt not_active Application Discontinuation
- 1995-05-09 CN CNB951940759A patent/CN1222286C/zh not_active Expired - Fee Related
- 1995-05-09 HU HU9603140A patent/HUT76327A/hu not_active Application Discontinuation
-
1996
- 1996-11-12 NO NO964793A patent/NO964793L/no not_active Application Discontinuation
- 1996-11-12 FI FI964537A patent/FI964537A/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0758892A1 (en) | 1997-02-26 |
CA2189528A1 (en) | 1995-11-23 |
FI964537A (fi) | 1997-01-10 |
NO964793L (no) | 1997-01-06 |
CN1152871A (zh) | 1997-06-25 |
HUT76327A (en) | 1997-08-28 |
HU9603140D0 (en) | 1997-01-28 |
CZ323496A3 (en) | 1997-10-15 |
AU709553B2 (en) | 1999-09-02 |
PL317192A1 (en) | 1997-03-17 |
CN1222286C (zh) | 2005-10-12 |
JPH10500671A (ja) | 1998-01-20 |
NZ285648A (en) | 1999-08-30 |
AU2512095A (en) | 1995-12-05 |
NO964793D0 (no) | 1996-11-12 |
WO1995031197A1 (en) | 1995-11-23 |
BR9507643A (pt) | 1997-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI964537A (fi) | Menetelmiä peroksinitriitin hajoamiskatalyyttien käyttämiseksi, farmaseuttisia koostumuksia sitä varten | |
DK0747050T4 (da) | Farmaceutiske sammensætninger, der indeholder irbesartan | |
HUP9900625A3 (en) | Benzimidazole derivatives, pharmaceutical compositions containing them and process for preparing the compounds | |
HUP0003309A3 (en) | Imidazolyl-cyclic acetals, process for producing them and pharmaceutical compositions containing the same | |
HUP9902455A3 (en) | 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them | |
DE59507593D1 (de) | Gaserzeugendes, azidfreies Stoffgemisch | |
NO976121D0 (no) | Fremgangsmåte for fremstilling av karbonylforbindelser | |
NO983068D0 (no) | FremgangsmÕte for fremstilling av bis-syklopentadienyl-dien komplekser | |
NO904222L (no) | Fremgangsmaate for fremstilling av benzodiazepiner. | |
NO20000355D0 (no) | Fremgangsmåte for fremstilling av cyklopropylacetylen | |
FI973644A (fi) | Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi | |
ZA97872B (en) | Use of pyrolidine derivatives for the manufacture of medicaments. | |
NO941648D0 (no) | Fremgangsmåte for fremstilling av katalysatorer | |
FI956058A (fi) | Menetelmä glutaaridialdehydin valmistamiseksi | |
NO985535L (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
FI101472B1 (fi) | Menetelmä 1,3-diolien monoesterien valmistamiseksi | |
DZ2302A1 (fr) | Produit pharmaceutique cristallin. | |
FI963466A0 (fi) | Menetelmä selluloosakarbamaatin valmistamiseksi | |
FI964829A0 (fi) | Menetelmä 2,2,4-trimetyyli-1,3-pentaanidioli-isobutyraatin valmistamiseksi | |
FI961178A (fi) | Menetelmä syklisten cis-1-amino-2-alkanolien valmistamiseksi | |
TR199601018A1 (tr) | Farmasötik bilesikler. | |
FI972694A0 (fi) | Uusi menetelmä sameridiinin valmistamiseksi | |
FI971964A0 (fi) | Menetelmä 1-halo-3-trialkyylisilasnyylibentseenijohdannaisten valmistamiseksi | |
FI961717A (fi) | Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |